© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Bioreactor Market to reach $1.9 billion by 2024: Global Market Insights Inc.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved  Global Market Insights, Inc. says Bioreactor Market size is set to exceed USD 1.9 billion by  Rising chronic disease prevalence and growing research in the field of biopharmaceuticals will drive the global bioreactor market size.  Personalized medicines are changing the way many diseases are identified, classified, and treated. The growing personalized medicine market that involves a focused population base will further drive the bioreactor market size.  Technological advances in manufacturing technology should improve flexibility, quality and scalability of operations with low capital and energy requirements.  Biopharmaceuticals are individualized products with highly specific manufacturing requirements. Advanced biopharmaceutical manufacturing technologies have enabled the development of effective drug delivery systems and drug device combination products. Key Insights from Bioreactor Market:

© 2016 Global Market Insights, Inc. USA. All Rights Reserved  Biopharmaceutical contract manufacturing outsourcing should drive the industry growth due to rising demand for biopharmaceuticals along with innovative drug products entering the clinical trials.  Large number of outsourcing services such as analytical, formulation, cell line development and small or large scale production related services should stimulate the business growth over the forecast years.  Mammalian cells market revenue is estimated to exceed USD 1.5 billion by It is widely used owing to its preference to product complex therapeutic proteins and enhanced compatibility for posttranslational modifications.  Monoclonal antibodies held more than 35% of the bioreactor market share in 2016, owing to increasing use in medical therapeutics attributed to its long half-life, high specificity, predictable pharmacokinetics, low toxicity, and high dose demand.  Single use bubble column bioreactor market size should witness over 18% CAGR over the forecast years. Continued...

© 2016 Global Market Insights, Inc. USA. All Rights Reserved  It is extensively used for cell line development, process development, and clinical trial manufacturing wherein they enhance the overall speed and effectiveness of media and cell line development.  U.S. bioreactor market size was valued at over USD 170 million in 2016 and is anticipated to witness significant growth over the coming years.  UK bioreactor market will witness over 17% CAGR, due to high healthcare spending and presence of large number of industry participants in this region.  APAC will experience significant gains due to a trend shift from traditional methods to new production methods of monoclonal antibodies, recombinant proteins, and cell culturing by using advanced bioreactors.  Bioreactor market participants are Eppendorf, GE Healthcare, Merck Millipore, Sartorius, Thermo Fisher Scientific, etc. Industry participants engage in strategic collaborations, mergers & acquisitions coupled with new product launches in order to achieve competitive edge. Continued...

© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Bioreactor Market Share, By Technology, 2016

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Browse Full Market Research Report On Bioreactor Request for a Sample of this Research

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Stay In Touch Website: Social Media: